Inovio Pharmaceuticals, Inc. (BMV:INO)

Inovio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	39.92	65.81	14.31	46.33	71.14	250.73
Short-Term Investments	28.45	28.3	130.98	206.67	330.17	160.91
Cash & Short-Term Investments	68.36	94.11	145.29	253	401.31	411.64
Cash Growth	-35.27%	-35.23%	-42.57%	-36.96%	-2.51%	359.76%
Receivables	1.31	1.2	2.41	11.74	8.03	19.06
Prepaid Expenses	2.22	2.52	5.41	20.51	39.1	4.8
Other Current Assets	-	-	-	30	-	35.66
Total Current Assets	71.89	97.83	153.11	315.24	448.44	471.17
Property, Plant & Equipment	11.09	11.77	14.45	17.96	29.02	24.09
Long-Term Investments	2.31	1.61	2.78	2.01	3.91	4.89
Goodwill	-	-	-	10.51	10.51	10.51
Other Intangible Assets	-	-	-	2.13	2.63	3.15
Other Long-Term Assets	1.98	1.98	0.61	0.68	1.43	25.96
Total Assets	87.27	113.2	170.95	348.53	495.94	539.77
Accounts Payable	5.52	6.44	4.65	21.08	27.97	1.47
Accrued Expenses	9.68	13.13	18.64	26.42	30.55	30.08
Current Portion of Long-Term Debt	-	-	16.77	-	-	-
Current Portion of Leases	2.58	2.5	2.41	2.8	2.6	2.33
Current Unearned Revenue	-	-	0.11	2.56	4.62	7.58
Other Current Liabilities	9.54	13.26	-	44	-	0.25
Total Current Liabilities	27.33	35.33	42.57	96.87	65.74	41.71
Long-Term Debt	-	-	-	16.61	14.96	18.66
Long-Term Leases	8.7	9.37	11.03	12.66	15.46	18.06
Long-Term Unearned Revenue	-	-	-	-	0.06	0.12
Long-Term Deferred Tax Liabilities	-	-	-	0.03	0.03	0.03
Other Long-Term Liabilities	-	-	-	-	0.01	0.06
Total Liabilities	36.02	44.69	53.6	126.17	96.27	78.63
Common Stock	0.04	0.04	0.02	0.02	0.22	0.19
Additional Paid-In Capital	1,802	1,799	1,741	1,711	1,610	1,367
Retained Earnings	-1,750	-1,730	-1,623	-1,488	-1,210	-906.2
Comprehensive Income & Other	-0.66	-0.68	-0.66	-0.7	-0.28	-0.26
Total Common Equity	51.25	68.5	117.35	222.36	399.67	461.14
Shareholders' Equity	51.25	68.5	117.35	222.36	399.67	461.14
Total Liabilities & Equity	87.27	113.2	170.95	348.53	495.94	539.77
Total Debt	11.27	11.87	30.21	32.07	33.02	39.05
Net Cash (Debt)	57.09	82.25	115.08	220.92	368.29	372.59
Net Cash Growth	-38.07%	-28.53%	-47.91%	-40.01%	-1.16%	-
Net Cash Per Share	1.84	3.03	5.19	11.11	21.16	28.82
Filing Date Shares Outstanding	36.67	36.67	23.37	21.68	18.12	17.3
Total Common Shares Outstanding	36.67	36.1	22.79	21.09	18.12	15.57
Working Capital	44.57	62.5	110.54	218.37	382.7	429.46
Book Value Per Share	1.40	1.90	5.15	10.54	22.06	29.62
Tangible Book Value	51.25	68.5	117.35	209.72	386.53	447.48
Tangible Book Value Per Share	1.40	1.90	5.15	9.94	21.34	28.74
Machinery	-	8.36	9.9	13.49	20.59	12.16
Leasehold Improvements	-	11.76	15.92	15.8	15.8	15.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.